Eisai GmbH
7 products tracked · names used in filings: Eisai GmbH
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Leqembi lecanemab | Authorised | 2025-04-15 |
| 🇪🇺 | Kisplyx lenvatinib | Authorised | 2016-08-25 |
| 🇪🇺 | Lenvima lenvatinib | Authorised | 2015-05-28 |
| 🇪🇺 | Fycompa perampanel | Authorised | 2012-07-23 |
| 🇪🇺 | Halaven eribulin | Authorised | 2011-03-17 |
| 🇪🇺 | Inovelon rufinamide | Authorised | 2007-01-16 |
| 🇪🇺 | Panretin alitretinoin | Withdrawn | 2000-10-11 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.